Identification of a Low-Risk Subgroup of HER-2-Positive Breast Cancer by the 70-gene Prognosis Signature

PUBLICATION: Br J Cancer. 2010 Dec 7; 103(12): 1788–1793. Published Read More

2024-03-07T11:51:48-05:00December 7th, 2010|Evidence, HER2-positive, MammaPrint, Other|

Comparison of MammaPrint and TargetPrint Results with Clinical Parameters in German Patients with Early Stage Breast Cancer

PUBLICATION: Int J Mol Med. 2010 Dec;26(6):837-43. AUTHORS: Gevensleben H., Read More

2024-03-25T10:58:17-04:00December 1st, 2010|Evidence, MammaPrint, Other|

Biological Functions of the Genes in the MammaPrint® Breast Cancer Profile Reflect the Hallmarks of Cancer

PUBLICATION: Biomarker Insights. 2010 Nov 28;5:129-38. doi: 10.4137/BMI.S6184. AUTHORS: Tian Read More

2024-03-25T10:58:58-04:00November 24th, 2010|Evidence, MammaPrint, Other, Validation|

Cost-effectiveness of the 70-gene Signature Versus St. Gallen Guidelines and Adjuvant Online for Early Breast Cancer

PUBLICATION: Eur J Cancer. 2010 May;46(8):1382-91. doi: 10.1016/j.ejca.2010.02.035. Epub 2010 Read More

2024-03-25T11:00:12-04:00May 2nd, 2010|Evidence, Healthcare Economics, MammaPrint, Other|

Metastatic Potential of T1 Breast Cancer Can Be Predicted by the 70-gene MammaPrint Signature

PUBLICATION: Ann Surg Oncol. 2010 May;17(5):1406-13. doi: 10.1245/s10434-009-0902-x. Epub 2010 Read More

2024-03-25T11:00:58-04:00May 1st, 2010|Adjuvant, Evidence, MammaPrint|

The 70-gene Signature as a Response Predictor for Neoadjuvant Chemotherapy in Breast Cancer

PUBLICATION: Breast Cancer Res Treat. 2010 Feb;119(3):551-8. doi: 10.1007/s10549-009-0333-1. Epub Read More

2024-03-25T11:03:35-04:00February 1st, 2010|Evidence, MammaPrint, Neoadjuvant|

The 70-gene Prognosis Signature Predicts Early Metastasis in Breast Cancer Patients Between 55 and 70 Years of Age

PUBLICATION: Ann Oncol. 2010 Apr;21(4):717-22. doi: 10.1093/annonc/mdp388. Epub 2009 Oct Read More

2024-03-25T11:06:57-04:00October 13th, 2009|Adjuvant, Evidence, MammaPrint|
Go to Top